Loading... (0%)

Posters/Publications

news

3­‐V Biosciences presented two publications at AASLD

03 December 2012

3­‐V Biosciences presented two publications at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (The Liver Meeting®) held November 9‐13 in Boston, Massachusetts. BACKGROUND: Optimized new therapies for HCV are needed that have pan genotypic activity and a high barrier to viral resistance. To meet these challenges, 3-V Biosciences…